Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login


Asthma care in England needs to be more proactive, researchers say

Despite 19 recommendations being made in the National Review of Asthma Deaths 2014 report, asthma care across England is still highly variable, research has shown

Lung function testing


Using data from 50 general practices caring for over 27,000 people with asthma, researchers cited a lack of personal asthma action plans and annual reviews among several other factors linked to asthma deaths

An audit of data from Bedfordshire Clinical Commissioning Group in England has found inconsistencies in asthma care that could leave high-risk patients unidentified and at risk of death[1].

The research looked at 50 general practices caring for 27,587 people with asthma in Bedfordshire.

The team identified several factors linked to asthma deaths, including excess short-acting reliever (e.g. salbutamol) and insufficient preventer (e.g. inhaled corticosteroid) prescriptions, as well as a lack of personal asthma action plans and annual reviews — including assessment of inhaler technique.

The audit was conducted in response to the National Review of Asthma Deaths 2014, which made 19 recommendations. However, the authors of this study have said these have not been fully implemented nationally.

They said they believed their findings were representative of the situation across the NHS in England.

“Modifications to existing systems within both primary and secondary care are required in order to prevent unnecessary deaths related to asthma,” the team wrote in Primary Care Respiratory Medicine (26 July 2018).

“There is a pressing need to move towards a more proactive model of care.”

Citation: Clinical Pharmacist DOI: 10.1211/CP.2018.20205414

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Lung function testing

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.